These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4258924)

  • 41. Comparative immunogenicity of various cellular and cell-free preparations in a leukemia isotransplant system.
    Tennant JR; Kingsley S
    J Natl Cancer Inst; 1971 Nov; 47(5):953-60. PubMed ID: 4330801
    [No Abstract]   [Full Text] [Related]  

  • 42. Antibody production in mice. VI. Effect of anti-carrier antibody on cellular co-operation in the primary anti-hapten antibody response.
    Takatsu K; Hamaoka T; Kitagawa M
    Immunology; 1974 Feb; 26(2):233-46. PubMed ID: 4546728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunological enhancement.
    Russell PS
    Transplant Proc; 1971 Mar; 3(1):960-6. PubMed ID: 4941150
    [No Abstract]   [Full Text] [Related]  

  • 44. Antibody-mediated in vivo suppression of EL4 leukemia in a syngeneic host.
    Zighelboim J; Bonavida B; Fahey JL
    J Natl Cancer Inst; 1974 Mar; 52(3):879-81. PubMed ID: 4826569
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of purine-protein conjugates on the Ehrlich ascites tumor in mice.
    Lachman C; Cohen S
    Cancer Res; 1970 Feb; 30(2):439-46. PubMed ID: 5441091
    [No Abstract]   [Full Text] [Related]  

  • 46. Influence of Ehrlich ascites carcinoma on repopulating ability of mouse bone marrow cells.
    Clerici E; Mocarelli P; Villa ML; Natale N
    J Natl Cancer Inst; 1971 Sep; 47(3):555-60. PubMed ID: 4945589
    [No Abstract]   [Full Text] [Related]  

  • 47. Immune stimulation-inhibition of experimental cancer metastasis.
    Fidler IJ
    Cancer Res; 1974 Mar; 34(3):491-8. PubMed ID: 4812256
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunologic and virologic properties of chemically and gamma-irradiation-induced thymic lymphomas in mice.
    Chan PL; Sinclair NR
    J Natl Cancer Inst; 1972 Jun; 48(6):1629-40. PubMed ID: 5066471
    [No Abstract]   [Full Text] [Related]  

  • 49. Tumor immunity in hamsters immunized with fetal tissues.
    Coggin JH; Ambrose KR; Bellomy BB; Anderson NG
    J Immunol; 1971 Aug; 107(2):526-33. PubMed ID: 4328010
    [No Abstract]   [Full Text] [Related]  

  • 50. Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.
    Vaage J
    Cancer Res; 1973 Mar; 33(3):493-503. PubMed ID: 4689898
    [No Abstract]   [Full Text] [Related]  

  • 51. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW; Benjamin SA
    J Natl Cancer Inst; 1972 Nov; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract]   [Full Text] [Related]  

  • 52. [Immunotherapy of neoplasms].
    Trepel F
    Med Klin; 1971 Feb; 66(7):222-9. PubMed ID: 4324109
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of Ehrlich ascites tumor growth by nucleoprotein. II. In vivo fate of the tumor cells.
    Bradshaw LJ; Webb DR
    J Natl Cancer Inst; 1969 Sep; 43(3):527-32. PubMed ID: 4980604
    [No Abstract]   [Full Text] [Related]  

  • 54. [The immunotherapeutic approaches to the management of leukemia and neoplasms].
    Leu TP
    Zhonghua Yi Xue Za Zhi; 1974 May; 5():310-4. PubMed ID: 4211699
    [No Abstract]   [Full Text] [Related]  

  • 55. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
    Kerbel RS
    Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979
    [No Abstract]   [Full Text] [Related]  

  • 56. Dynamics of immunologic enhancement.
    Kaliss N
    Transplant Proc; 1970 Mar; 2(1):59-67. PubMed ID: 4940355
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 58. [Interference of immunological factors in the antitumoral activity of sarcolysine].
    Bonmassar E; Castagnone D; Celi ML; Melan F
    Arch Ital Patol Clin Tumori; 1968; 11(1):215-28. PubMed ID: 5745129
    [No Abstract]   [Full Text] [Related]  

  • 59. Reversibility of the immunodepression due to Ehrlich ascites carcinoma.
    Mocarelli P; Villa ML; Garotta G; Porta C; Bigi G; Clerici E
    J Immunol; 1973 Sep; 111(3):973-5. PubMed ID: 4582265
    [No Abstract]   [Full Text] [Related]  

  • 60. Investigations on mononuclear cells of animals sensitized against homologous normal tissue transplants and tumor transplants.
    Warnatz H
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):748-52. PubMed ID: 5334579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.